Dr David Solomon joins Zealand Pharma
This article was originally published in Scrip
Executive Summary
Zealand Pharma (Denmark) has named Dr David Solomon chief executive officer. Most recently, Dr Solomon served as chief operating officer of Vital Sensors. He has experience in pharmacology research, having served as a faculty member at Columbia University's College of Physicians and Surgeons in New York, as well as leadership positions at several biotechnology, pharmaceutical and medical device companies, including Remedy Pharmaceuticals and Critical Diagnostics.
You may also be interested in...
Gene Therapy Approvals By US FDA Could Double In 2020
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Long Hot Summer For Novel Drug Reviews Forecast At US FDA
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Need a specific report? 1000+ reports available
Buy Reports